Key result
Probiotics significantly increase serum adiponectin and VEGF compared with placebo in prediabetic patients.
Why the study?
The ability of probiotics to improve glycolipid metabolism and slow the progression of prediabetes to diabetes mellitus is debated, and their effects on resistin, adiponectin, and VEGF in prediabetic patients required evaluation.
Does daily probiotic supplementation (500 mg, 10^9 CFU) improve serum VEGF and adiponectin levels and glycolipid metabolism in newly diagnosed prediabetic patients over 3 months?
RCT (n=52)
Double-blind
computer-based block randomization approach (fixed block size of 4)
No
Does daily probiotic supplementation (500 mg, 10^9 CFU) improve serum VEGF and adiponectin levels and glycolipid metabolism in newly diagnosed prediabetic patients over 3 months?
In newly diagnosed prediabetic patients, 3 months of daily probiotic supplementation added to lifestyle modifications significantly improved glycolipid metabolism, reduced estimated ASCVD risk, and increased serum adiponectin and VEGF levels compared to placebo.
Answers are grounded in this paper and cite their sources.
Supports adjunctive probiotics in prediabetes management; extends RCT evidence on microbiome modulation of adipokines.
It is debated that probiotics can improve glycolipid metabolism and slow the progression of prediabetes to diabetes mellitus. This study aimed to evaluate the effect of probiotics on lipid profile, glucose homeostasis, serum level of resistin, adiponectin, and vascular endothelial growth factor (VEGF) in prediabetic patients. This double‐blind, randomized, placebo‐controlled clinical trial was conducted on prediabetic patients in the Endocrinology clinic of Ghaem Hospital. Patients were randomly divided into two groups: the probiotics group was prescribed a daily 500‐mg capsule of probiotics (109 colony‐forming units), while the other received a placebo capsule with the same appearance. After 3 months, the effect of probiotic administration on laboratory parameters indicative of glycolipid metabolism, resistin, adiponectin, VEGF, body mass index (BMI), and blood pressure was compared between groups. This study was registered in the Iranian Registry of Clinical Trials (IRCT 20190801044405 N2). Fifty‐two patients were included in the final analysis, with 26 patients in each group. The mean age of patients was 43.75 ± 8.45. At the beginning, both groups were similar in all demographic characteristics and measured serum levels of investigated biomarkers (p > 0.05 for all parameters). Both groups exhibited significant changes in BMI and fasting blood sugar (FBS). However, regarding FBS, the magnitude of change was significantly greater in patients treated with probiotics (p = 0.022). Our findings also revealed a significant increase in HDL (p = 0.001), adiponectin (p < 0.001), and VEGF (p = 0.024) serum levels and a significant decrease in HbA1c (p = 0.034), LDL (p = 0.002), TG (p < 0.001), and total cholesterol (p = 0.001) exclusively in the probiotics group. Probiotic supplementation efficiently improved glycolipid metabolism, adiponectin, and VEGF serum levels.
No takes yet. Share an insight, caveat, or question.
Sarabi et al. (2025) conducted an RCT in Prediabetes (n=52). Multi-strain probiotics capsule vs. Placebo capsule with the same weight and appearance, plus lifestyle modification in both groups was evaluated on 3-month change in serum adiponectin (μg/mL) (co-primary with VEGF) (p=<0.001). Daily probiotic supplementation for 3 months increased serum adiponectin and VEGF compared with placebo in prediabetic patients.
Synapse has enriched 10 related papers. Consider them for comparative context: